-
New Insights from the MARGOT/TBCRC052 Trial on HER2+ Breast Cancer Treatment
The MARGOT/TBCRC052 trial, presented at SABCS 2024, explored the efficacy of margetuximab + paclitaxel + pertuzumab (TMP) versus the standard trastuzumab + paclitaxel + pertuzumab (THP) in HER2+ stage II-III…
-
Throwback to #SABCS24: Key Insights from the ZEST Trial
Prof. Nicholas Turner and colleagues presented findings from ZEST, the first Phase 3 trial evaluating MRD-guided therapy in breast cancer using circulating tumor DNA (ctDNA) surveillance.
-
New Insights on Tamoxifen Use After Breast Conservation Surgery for DCIS!
At SABCS, Jean Wright presented a new analysis from the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 trials, providing critical insights into the role of tamoxifen for patients with “good risk”…
-
Advancing Precision Medicine in Prostate Cancer: Expert Insights from Professor Qiu Xuefeng & Dr. Darren Poon
How are PARP inhibitors, ARPIs, and radioligand therapy reshaping the treatment landscape for mCRPC? In this exclusive conversation, Professor Qiu Xuefeng and Dr. Darren Poon dive into the latest advancements in precision oncology, discussing key challenges, emerging therapies, and the impact of HRR and BRCA testing on treatment decisions.
-
Throwback to #SABCS24: Final Survival Results from the ADAPT HR+/HER2- Trial
Prof. Sherko Kuemmel and the WSG Study Group presented key findings from the ADAPT HR+/HER2- chemotherapy trial, refining treatment strategies for high-risk HR+/HER2- early breast cancer.
-
WCLC 2024 | Selected Oral Presentations: Novel Immunotherapy Strategies and Combination Therapies
The 2024 World Conference on Lung Cancer is happening in San Diego from September 7th to 10th! The WCLC website has already released some groundbreaking abstracts. Here are the key…
-
WCLC 2024 | Selected Oral Presentations: Treatment of Pleural Mesothelioma, Thymic Carcinoma, and Undifferentiated Thoracic Tumors
The 2024 World Conference on Lung Cancer is happening in San Diego from September 7th to 10th! The WCLC website has already released important abstracts. Below are some key research…
-
WCLC 2024 | Selected Oral Presentations: Multimodal Treatment of Stage III Lung Cancer
The 2024 World Conference on Lung Cancer is taking place in San Diego from September 7th to 10th! Some key abstracts have already been released. Here’s an overview of the…
Connecting Medical Expertise through Media